Latest News in the pharma Industry

Market News

CPhI Worldwide announces the board of Judges for the CPhI Pharma Awards 2016

CPhI Worldwide announces the board of Judges for the CPhI Pharma Awards 2016

11 Aug 2016

CPhI Pharma Awards’ panel doubles in size and welcomes top experts from around the world.

Read more 
Celsion and Zhejiang Hisun sign technology transfer, manufacturing and commercial supply agreement for the development of its GEN-1 immuno-oncology therapy

Celsion and Zhejiang Hisun sign technology transfer, manufacturing and commercial supply agreement for the development of its GEN-1 immuno-oncology therapy

11 Aug 2016

Expanded partnership provides capacity and cost structure supporting Celsion's global commercial strategy for GEN-1.

Read more 
Agilent to build new facility in Colorado, increasing pharmaceutical manufacturing capacity

Agilent to build new facility in Colorado, increasing pharmaceutical manufacturing capacity

11 Aug 2016

Expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid APIs.

Read more 
Automation-ready blowdown evaporator available from Porvair Sciences

Automation-ready blowdown evaporator available from Porvair Sciences

10 Aug 2016

The Ultravap Levante will appeal to the budget-conscious laboratory who may wish to automate their sample dry-down bottleneck in the future.

Read more 
New entrants will propel ophthalmological disorders market to $26 billion by 2022

New entrants will propel ophthalmological disorders market to $26 billion by 2022

10 Aug 2016

Angiogenesis modulators and gene therapies to boost overall revenue within the forecast period.

Read more 
Biogen announces Bioverativ as name of new hemophilia-focused company

Biogen announces Bioverativ as name of new hemophilia-focused company

9 Aug 2016

Bioverativ will focus on accelerating innovation for people living with hemophilia and other blood disorders.

Read more 
Microbiological environmental monitoring features in two national conferences supported by Cherwell Laboratories

Microbiological environmental monitoring features in two national conferences supported by Cherwell Laboratories

9 Aug 2016

Cherwell to offer expert insight in environmental monitoring and process validation to both NHS and industrial pharmaceutical manufacturers.

Read more 
Vonvendi, the first and only recombinant treatment for adults affected by von Willebrand disease, launches in the US

Vonvendi, the first and only recombinant treatment for adults affected by von Willebrand disease, launches in the US

9 Aug 2016

Vonvendi is a significant advancement for the treatment of adults with von Willebrand disease.

Read more 
University of Pittsburgh licenses novel microneedle patch to SkinJect

University of Pittsburgh licenses novel microneedle patch to SkinJect

9 Aug 2016

SkinJect Microneedle Patch to deliver drug to treat and immunize skin cancer patients.

Read more 
Charles River Laboratories announces partnership with the Milner Therapeutics Institute and Consortium

Charles River Laboratories announces partnership with the Milner Therapeutics Institute and Consortium

9 Aug 2016

Through this partnership, the academic institutions in the Consortium will have access to Charles River’s early discovery and drug development resources and services to accelerate their early-stage drug development processes.

Read more 
Dr Reddy’s completes acquisition of product portfolio from TEVA

Dr Reddy’s completes acquisition of product portfolio from TEVA

8 Aug 2016

The portfolio is a mix of six ANDAs pending approval, one approved ANDA and one ANDA with tentative approval, and comprises complex generic products across diverse dosage forms.

Read more 
SMC ‘U-turn’ offers lifeline to Scottish skin cancer patients

SMC ‘U-turn’ offers lifeline to Scottish skin cancer patients

8 Aug 2016

Opdivo (nivolumab) now recommended to treat Scottish NHS patients with advanced skin cancer.

Read more